These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33465401)

  • 1. Vasculogenic mimicry, a complex and devious process favoring tumorigenesis - Interest in making it a therapeutic target.
    Treps L; Faure S; Clere N
    Pharmacol Ther; 2021 Jul; 223():107805. PubMed ID: 33465401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell vascular mimicry: Novel targeting opportunity in melanoma.
    Hendrix MJ; Seftor EA; Seftor RE; Chao JT; Chien DS; Chu YW
    Pharmacol Ther; 2016 Mar; 159():83-92. PubMed ID: 26808163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced research on vasculogenic mimicry in cancer.
    Qiao L; Liang N; Zhang J; Xie J; Liu F; Xu D; Yu X; Tian Y
    J Cell Mol Med; 2015 Feb; 19(2):315-26. PubMed ID: 25598425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasculogenic mimicry in carcinogenesis and clinical applications.
    Luo Q; Wang J; Zhao W; Peng Z; Liu X; Li B; Zhang H; Shan B; Zhang C; Duan C
    J Hematol Oncol; 2020 Mar; 13(1):19. PubMed ID: 32169087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cell vasculogenic mimicry: from controversy to therapeutic promise.
    Seftor RE; Hess AR; Seftor EA; Kirschmann DA; Hardy KM; Margaryan NV; Hendrix MJ
    Am J Pathol; 2012 Oct; 181(4):1115-25. PubMed ID: 22944600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
    Zheng N; Zhang S; Wu W; Zhang N; Wang J
    Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications.
    Kirschmann DA; Seftor EA; Hardy KM; Seftor RE; Hendrix MJ
    Clin Cancer Res; 2012 May; 18(10):2726-32. PubMed ID: 22474319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of advances in vasculogenic mimicry - a potential target for tumor therapy.
    Ge H; Luo H
    Cancer Manag Res; 2018; 10():2429-2437. PubMed ID: 30122992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment.
    Li S; Meng W; Guan Z; Guo Y; Han X
    Biomed Pharmacother; 2016 May; 80():127-135. PubMed ID: 27133049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions.
    Liu Q; Qiao L; Liang N; Xie J; Zhang J; Deng G; Luo H; Zhang J
    J Cell Mol Med; 2016 Sep; 20(9):1761-9. PubMed ID: 27027258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy checkpoints in ovarian cancer vasculogenic mimicry: Tumor immune microenvironments, and drugs.
    Hu H; Ma T; Liu N; Hong H; Yu L; Lyu D; Meng X; Wang B; Jiang X
    Int Immunopharmacol; 2022 Oct; 111():109116. PubMed ID: 35969899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas.
    Sun B; Zhang S; Zhao X; Zhang W; Hao X
    Int J Oncol; 2004 Dec; 25(6):1609-14. PubMed ID: 15547697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry.
    Zhang X; Zhang J; Zhou H; Fan G; Li Q
    J Cancer; 2019; 10(25):6327-6340. PubMed ID: 31772665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of vasculogenic mimicry in astrocytomas and effects of Endostar on U251 cells.
    Liu Z; Li Y; Zhao W; Ma Y; Yang X
    Pathol Res Pract; 2011 Oct; 207(10):645-51. PubMed ID: 21940112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Overview of Vasculogenic Mimicry in Breast Cancer.
    Andonegui-Elguera MA; Alfaro-Mora Y; Cáceres-Gutiérrez R; Caro-Sánchez CHS; Herrera LA; Díaz-Chávez J
    Front Oncol; 2020; 10():220. PubMed ID: 32175277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers.
    Morales-Guadarrama G; García-Becerra R; Méndez-Pérez EA; García-Quiroz J; Avila E; Díaz L
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
    Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
    Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.
    Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y
    Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting vasculogenic mimicry by phytochemicals: A potential opportunity for cancer therapy.
    Haiaty S; Rashidi MR; Akbarzadeh M; Maroufi NF; Yousefi B; Nouri M
    IUBMB Life; 2020 May; 72(5):825-841. PubMed ID: 32026601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.
    Wei X; Chen Y; Jiang X; Peng M; Liu Y; Mo Y; Ren D; Hua Y; Yu B; Zhou Y; Liao Q; Wang H; Xiang B; Zhou M; Li X; Li G; Li Y; Xiong W; Zeng Z
    Mol Cancer; 2021 Jan; 20(1):7. PubMed ID: 33397409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.